rxstat › Shortages › Palonosetron

Palonosetron shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Palonosetron products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 2
In shortage since
Jun 23, 2022
Reports on file
5
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
ALOXI
0.5MG · CAPSULE · ELVIUM LIFE SCIENCES
DIN 02381729 · since Jun 23, 2022, no end estimate · Delay in shipping of the drug.
Resolved
ALOXI
0.5MG · CAPSULE · ELVIUM LIFE SCIENCES
DIN 02381729 · ended Sep 24, 2021 · Requirements related to complying with good manufacturing practices.
Resolved
ALOXI
0.5MG · CAPSULE · PURDUE PHARMA
DIN 02381729 · ended Mar 27, 2020 · Other (Please describe in comments)
Resolved
ALOXI
PURDUE PHARMA
DIN 02381710 · ended Oct 23, 2017 · Disruption of the manufacture of the drug.
reversed
ALOXI
0.25MG · SOLUTION · PURDUE PHARMA
DIN 02381710

What's happening

Palonosetron is currently affected by an active shortage report filed with Health Canada by ELVIUM LIFE SCIENCES.

The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Palonosetron is classified under “ANTIEMETICS AND ANTINAUSEANTS” (ATC A04AA).

Recent changes

Common questions

When will Palonosetron be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Palonosetron in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiemetics and antinauseants)

Widespread shortageGranisetron2 of 2 reported products affected · est. return Jul 24, 2026Partial shortageOndansetron11 of 54 reported products affected · est. return Oct 30, 2026DiscontinuedAprepitant0 of 2 reported products affectedDiscontinuedAprepitant Aprepitant0 of 1 reported products affectedShortage anticipatedFosaprepitant0 of 1 reported products affectedNo current shortageNabilone

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.